Progress and controversies in neoadjuvant therapy

被引：0

作者：

Edwin M. Posadas

Robert A. Figlin

机构：

[1] Urologic Oncology Program,

[2] Samuel Oschin Comprehensive Cancer Institute,undefined

[3] Cedars–Sinai Medical Center,undefined

来源：

Nature Reviews Urology | 2014年 / 11卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Use of clinically active agents, such as kinase inhibitors, before nephrectomy is safe and feasible and can decrease the size of primary tumours, enabling optimization of the surgical approach. However, the overall clinical benefit of the neoadjuvant use of toxic drugs, such as axitinib, has not yet been demonstrated.

引用

页码：254 / 256

页数：2

共 50 条

[1] KIDNEY CANCER Progress and controversies in neoadjuvant therapy
Posadas, Edwin M.
Figlin, Robert A.
NATURE REVIEWS UROLOGY, 2014, 11 (05) : 254 - 255
[2] Navigating the landscape of neoadjuvant immunotherapy for NSCLC: progress and controversies
Chen, Yuzhu
Qi, Fei
Sun, Chenhao
Jiang, Peng
Xue, Xiangyu
Yang, Xiaomei
Li, Xiaomi
He, Xin
Wang, Yishuo
Zhang, Tongmei
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2025, 17
[3] Controversies in breast cancer: adjuvant and neoadjuvant therapy
Montemurro, F
Redana, S
Valabrega, G
Aglietta, M
EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (07) : 1055 - 1072
[4] Current Controversies in Neoadjuvant Therapy for Pancreatic Cancer
Ward, Erin P.
Zeh, Herbert J., III
Tsai, Susan
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 30 (04) : 657 - 671
[5] Progress and Controversies: Radiation Therapy for Prostate Cancer
Martin, Neil E.
D'Amico, Anthony V.
CA-A CANCER JOURNAL FOR CLINICIANS, 2014, 64 (06) : 389 - 407
[6] Progress in neoadjuvant therapy for gastric cancer
Su, Peng-Fei
Yu, Jian-Chun
ONCOLOGY LETTERS, 2022, 23 (06)
[7] Management of the Axilla After Neoadjuvant Therapy: Current Data and Controversies
Gangi A.
Choi M.
Giuliano A.E.
Current Breast Cancer Reports, 2014, 6 (4) : 283 - 288
[8] Progress and controversies: Radiation therapy for invasive breast cancer
Jagsi, Reshma
CA-A CANCER JOURNAL FOR CLINICIANS, 2014, 64 (02) : 135 - 152
[9] Controversies Concerning the Use of Neoadjuvant Systemic Therapy for Primary Breast Cancer
Kaufmann, Manfred
Karn, Thomas
Ruckhaeberle, Eugen
WORLD JOURNAL OF SURGERY, 2012, 36 (07) : 1480 - 1485
[10] Neoadjuvant Therapy As a Platform for Drug Development: Current Controversies and Regulatory Perspectives
Amiri-Kordestani, Laleh
Beaver, Julia A.
Cortazar, Patricia
ONCOLOGY-NEW YORK, 2015, 29 (11): : 843 - +

← 1 2 3 4 5 →